Skip to main content
Erschienen in: Supportive Care in Cancer 7/2021

06.01.2021 | Original Article

Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit

verfasst von: Tugba Cetintepe, Lutfi Cetintepe, Serife Solmaz, Sebnem Calık, Mehmet Can Ugur, Fusun Gediz, Oktay Bilgir

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Febrile neutropenia (FN) is a hematological emergency. It is challenging and confusing for the clinicians to make the decision of the febrile neutropenic patients under chemotherapy to be monitored at intensive care unit (ICU). The aim of this study was to define the factors supporting decision-making for the critical patients with febrile neutropenia.

Methods

The data of 60 patients, who were taken to the ICU while they were under treatment in the Hematology Clinic with a diagnosis of febrile neutropenia, were analyzed retrospectively, in order to identify clinically useful prognostic parameters.

Results

The ICU mortality rate was 80%. Mortality was significantly associated with higher sequential organ failure assessment score (SOFA), quick sequential organ failure assessment score (qSOFA), and hematological SOFA (SOFAhem) scores on admission. All cases having SOFA score 10 and above and qSOFA score 2 and above died. In multivariate analysis, qSOFA score was found to be statistically significant in predicting mortality in regard to ICU admission (p = 0.004).

Conclusion

Mortality of febrile neutropenic patients admitted to ICU is high. It would be appropriate to determine the extent of organ dysfunction instead of underlying disease, for making the decision of ICU admission. It should be noticed that the risk mortality is high for the FN cases with SOFA score 10 or above, qSOFA score 2 or above, and in need of mechanical ventilation and positive inotropic support; hence, early intervention is recommended. In our study, the most significant parameter in predicting ICU mortality was found to be qSOFA.
Literatur
1.
Zurück zum Zitat Azoulay E, Pène F, Darmon M, Lengliné E, Benoit D, Soares M et al (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29(6):359–367CrossRef Azoulay E, Pène F, Darmon M, Lengliné E, Benoit D, Soares M et al (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29(6):359–367CrossRef
2.
Zurück zum Zitat Uys A, Rapoport BL, Anderson R (2004) Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer 12:555–560CrossRef Uys A, Rapoport BL, Anderson R (2004) Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer 12:555–560CrossRef
3.
Zurück zum Zitat Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93CrossRef Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93CrossRef
4.
Zurück zum Zitat Baden LR et al (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 14(7):882–913CrossRef Baden LR et al (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 14(7):882–913CrossRef
5.
Zurück zum Zitat Flowers CR, Seidenfeld J, Bow EJ et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(6):794–810CrossRef Flowers CR, Seidenfeld J, Bow EJ et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(6):794–810CrossRef
6.
Zurück zum Zitat de Naurois J, Novitzky-Basso I, Gill MJ et al (2010) Management of febrile neutropenia: ESMO clinical practice guidelines. Ann Oncol 21(Suppl 5):v252–v256CrossRef de Naurois J, Novitzky-Basso I, Gill MJ et al (2010) Management of febrile neutropenia: ESMO clinical practice guidelines. Ann Oncol 21(Suppl 5):v252–v256CrossRef
7.
Zurück zum Zitat Magid T, Haase N, Andersen JS, Nielsen OJ, Bonde J (2012) Intensive care of haematological patients. Dan Med J 59(3):A4395PubMed Magid T, Haase N, Andersen JS, Nielsen OJ, Bonde J (2012) Intensive care of haematological patients. Dan Med J 59(3):A4395PubMed
8.
Zurück zum Zitat Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens YE, Avondo A, Occelli C, Feral-Pierssens AL, Truchot J, Ortega M, Carneiro B, Pernet J, Claret PG, Dami F, Bloom B, Riou B (2017) Beaune S; French Society of Emergency Medicine Collaborators Group. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA. 317(3):301–308CrossRef Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens YE, Avondo A, Occelli C, Feral-Pierssens AL, Truchot J, Ortega M, Carneiro B, Pernet J, Claret PG, Dami F, Bloom B, Riou B (2017) Beaune S; French Society of Emergency Medicine Collaborators Group. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA. 317(3):301–308CrossRef
9.
Zurück zum Zitat Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800CrossRef Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800CrossRef
10.
Zurück zum Zitat Geerse DA, Span LF, Pinto-Sietsma SJ, vanMook WN (2011) Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med 22(1):57–61CrossRef Geerse DA, Span LF, Pinto-Sietsma SJ, vanMook WN (2011) Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med 22(1):57–61CrossRef
11.
Zurück zum Zitat Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC (2012) Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 108(3):452–459CrossRef Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC (2012) Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 108(3):452–459CrossRef
12.
Zurück zum Zitat Demandt AMP, Geerse DA, Janssen BJP, Winkens B, Schouten HC, vanMook WNKA (2017) The prognostic value of a trend in modified SOFA score for patients with hematological malignancies in the intensive care unit. Eur J Haematol 99(4):315–322CrossRef Demandt AMP, Geerse DA, Janssen BJP, Winkens B, Schouten HC, vanMook WNKA (2017) The prognostic value of a trend in modified SOFA score for patients with hematological malignancies in the intensive care unit. Eur J Haematol 99(4):315–322CrossRef
13.
Zurück zum Zitat Liu J, Cheng Q, Yang Q, Li X, Shen X, Zhang L, Liu Z, Khoshnood K (2015) Prognosis related factors in intensive care unit (ICU) patients with hematological malignancies: a retrospective cohort analysis in a Chinese population. Hematology 20(9):494–503CrossRef Liu J, Cheng Q, Yang Q, Li X, Shen X, Zhang L, Liu Z, Khoshnood K (2015) Prognosis related factors in intensive care unit (ICU) patients with hematological malignancies: a retrospective cohort analysis in a Chinese population. Hematology 20(9):494–503CrossRef
14.
Zurück zum Zitat Yeo CD, Kim JW, Kim SC, Kim YK, Kim KH, Kim HJ, Lee S, Rhee CK (2012) Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care 27(6):739.e1–739.e6CrossRef Yeo CD, Kim JW, Kim SC, Kim YK, Kim KH, Kim HJ, Lee S, Rhee CK (2012) Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care 27(6):739.e1–739.e6CrossRef
15.
Zurück zum Zitat Evison J, Rickenbacher P, Ritz R, Gratwohl A, Haberthur C, Elsasser S et al (2001) Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 131:681–686PubMed Evison J, Rickenbacher P, Ritz R, Gratwohl A, Haberthur C, Elsasser S et al (2001) Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 131:681–686PubMed
16.
Zurück zum Zitat Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A et al (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30:2260–2270CrossRef Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A et al (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30:2260–2270CrossRef
17.
Zurück zum Zitat Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G et al (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 28:1294–1300CrossRef Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G et al (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 28:1294–1300CrossRef
18.
Zurück zum Zitat Vandijck DM, Depuydt PO, Offner FC, Nollet J, Peleman RA, Steel E, Noens LA, Decruyenaere JM, Benoit DD (2010) Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies. Intensive Care Med 36(10):1744–1750CrossRef Vandijck DM, Depuydt PO, Offner FC, Nollet J, Peleman RA, Steel E, Noens LA, Decruyenaere JM, Benoit DD (2010) Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies. Intensive Care Med 36(10):1744–1750CrossRef
19.
Zurück zum Zitat Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31(1):104–112CrossRef Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31(1):104–112CrossRef
20.
Zurück zum Zitat Calik S, Ari A, Bilgir O, Cetintepe T, Yis R, Sonmez U, Tosun S (2018) The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies. Saudi Med J 39(9):878–885CrossRef Calik S, Ari A, Bilgir O, Cetintepe T, Yis R, Sonmez U, Tosun S (2018) The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies. Saudi Med J 39(9):878–885CrossRef
21.
Zurück zum Zitat Cornet AD, Issa AI, van de Loosdrecht AA, Ossenkoppele GJ, Strackvan Schijndel RJ, Groeneveld AB (2005) Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 74(6):511–516CrossRef Cornet AD, Issa AI, van de Loosdrecht AA, Ossenkoppele GJ, Strackvan Schijndel RJ, Groeneveld AB (2005) Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 74(6):511–516CrossRef
22.
Zurück zum Zitat Kim M, Ahn S, Kim WY, Sohn CH, Seo DW, Lee YS, Lim KS (2017) Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia. Support Care Cancer 25(5):1557–1562CrossRef Kim M, Ahn S, Kim WY, Sohn CH, Seo DW, Lee YS, Lim KS (2017) Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia. Support Care Cancer 25(5):1557–1562CrossRef
23.
Zurück zum Zitat Lee SJ, Kim JH, Han SB, Paik JH, Durey A (2018) Prognostic factors predicting poor outcome in cancer patients with febrile neutropenia in the emergency department: usefulness of qSOFA. J Oncol 2018:2183179CrossRef Lee SJ, Kim JH, Han SB, Paik JH, Durey A (2018) Prognostic factors predicting poor outcome in cancer patients with febrile neutropenia in the emergency department: usefulness of qSOFA. J Oncol 2018:2183179CrossRef
24.
Zurück zum Zitat Feld R (2008) Blood stream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 32(Suppl 1):S30–S33CrossRef Feld R (2008) Blood stream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 32(Suppl 1):S30–S33CrossRef
Metadaten
Titel
Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit
verfasst von
Tugba Cetintepe
Lutfi Cetintepe
Serife Solmaz
Sebnem Calık
Mehmet Can Ugur
Fusun Gediz
Oktay Bilgir
Publikationsdatum
06.01.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05924-w

Weitere Artikel der Ausgabe 7/2021

Supportive Care in Cancer 7/2021 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.